2023 Fall Meeting

Presentation information

Oral presentation

III. Fission Energy Engineering » 301-3 Research Reactor, Application of Neutron

[3M05-08] Medical RI Production 2

Fri. Sep 8, 2023 10:50 AM - 11:55 AM Room M (ES Bildg. 3F ES034)

Chair:Naoto Aizawa(Tohoku Univ.)

11:20 AM - 11:35 AM

[3M07] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(7) Manufacturing conditions for medical use of 225Ac

*Anri Inaki1, Takeo Morooka2, Naoyuki Takaki3 (1. National Cancer Center Japan, 2. Japan Medical Radioisotope Inc., 3. Tokyo City University)

Keywords:Nuclear Medicine

A drug master file (DMF) is a document that domestic or foreign manufacturers of drug substances submit as an information for theire manufacturing methods, manufacturing control, quality control, etc. As a result, manufacturers of drugs can apply for approval without disclosing information about drug substances.
In order to spread the research and development of 225Ac for medical use that manufactured in nuclear reactors in Japan, it is the best way that manufacturers of 225Ac for medical use register it with the DMF.
We discussed the quality requirements for 225Ac derived from nuclear reactors based on the quality requirements for 225Ac that have already been clinically applied in Europe and the United States.

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password